<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recent clinical studies that evaluated the effects of supplemental omega-3 polyunsaturated fatty acids (n-3 PUFAs) on <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> have yielded conflicting results </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to clarify this issue using an established and clinical relevant canine model of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Susceptibility to <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) was evaluated using a 2-minute left circumflex <z:mp ids='MP_0006134'>artery occlusion</z:mp> during the last minute of an exercise test in 76 dogs (from 2 independent studies) with healed <z:hpo ids='HP_0001658'>myocardial infarctions</z:hpo> (MI); 44 developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> (susceptible, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>+), whereas 32 did not (resistant, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>-) </plain></SENT>
<SENT sid="3" pm="."><plain>These dogs were then randomly assigned to either placebo (1 g/d, corn oil; 15 VF+, 11 VF-) or n-3 PUFA (1-4 g/d, <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi>+eicosapentaenoic acid ethyl <z:chebi fb="21" ids="35701">esters</z:chebi>, 29 VF+, 21 VF-) groups </plain></SENT>
<SENT sid="4" pm="."><plain>Seven sham (no-MI) dogs were also treated with n-3 PUFA (4 g/d) </plain></SENT>
<SENT sid="5" pm="."><plain>After treatment (3 months), the exercise+<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> test was repeated </plain></SENT>
<SENT sid="6" pm="."><plain>Dietary n-3 PUFAs produced significant (P&lt;0.01) increases in red blood cell and left ventricular n-3 PUFA levels </plain></SENT>
<SENT sid="7" pm="."><plain>Nine <z:e sem="disease" ids="C0856742" disease_type="Disease or Syndrome" abbrv="">post-MI</z:e> (5 placebo versus 4 n-3 PUFA) and 2 sham dogs died suddenly during the 3-month treatment period </plain></SENT>
<SENT sid="8" pm="."><plain>The n-3 PUFA treatment failed to prevent <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>+ dogs (decreased in 27% placebo versus 24% n-3 PUFA, P=0.5646) but induced VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>- animals (n-3 PUFA 33% versus placebo 0%, P=0.0442) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Despite large increases in cardiac tissue n-3 PUFA content, dietary n-3 PUFAs did not prevent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> and actually increased <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> susceptibility in both noninfarcted and low-risk <z:e sem="disease" ids="C0856742" disease_type="Disease or Syndrome" abbrv="">post-MI</z:e> dogs </plain></SENT>
</text></document>